Purchasing a car with MS in mind
This week Rosie Farrell shares tips and a checklist when buying a car.
This week Rosie Farrell shares tips and a checklist when buying a car.
Our information seminars will be hosted online (zoom) for people who have been diagnosed with MS plus a partner/friend if you wish. The online seminars will be held on Saturday 7th and 14th November 2020. Keynote speakers will include a Neurologist and Neuropsychologist, as well as speakers on topics such as exercise, managing stress and mindfulness.
Multiple Sclerosis International Federation global advice has just been updated. Find out about risk factors, prevention measures & advice on using different disease modifying therapies during the pandemic
This week Rosie Farrell shares her experience of what it means to have fatigue and how she deals with it.
Are you currently accessing any supports and services online for your Neurological condition?
Registration for the EMSP's Annual Conference on the 19th and 20th of November is now officially open!
World Mental Health Day is marked on Saturday, 10th October 2020. MS and depression can be a very challenging experience, today Joan Jordan shares her story.
The National Transport Authority are interested in hearing the views and concerns of people across Ireland in relation to accessibility of public transport in their area. They have created a survey which they have asked us to share with you.
Today, October 6th marks the first ever European Carers Day. Mary Devereux shares her thoughts on why carers need more care.
Ocrevus (ocrelizumab) is the first and only licensed treatment for people with early, inflammatory primary progressive multiple sclerosis in Ireland.
Dublin, 1st of October 2020 – Roche Products (Ireland) Ltd. (“Roche”), today, announced that OCREVUS® (ocrelizumab) is now publicly available in Ireland to treat people living with primary progressive multiple sclerosis (PPMS). More than 9,000 people in Ireland are living with MS(1) and it is estimated that PPMS, a highly disabling form of MS, and according to MS Ireland, affects approximately 15% of people diagnosed with MS(1).
© 2010 - 2024 Multiple Sclerosis Society of Ireland